InsidersTradesSigma
Track the 同和药业 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 同和药业 has recorded 13 public disclosures. Market capitalisation: €2.8bn. The latest transaction was disclosed on 9 December 2021 (Purchase). Among the most active insiders: 庞正伟. The full history is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€9m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
36Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,215 of 29,062 companies
41.3
score / 100
Value37
Quality46
FCF yld-3.2%
Earn yld2.6%
EV/EBITDA15.7x
ROE3.0%
Gross mgn30%
Net mgn8.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 December 2021
Declarations13 total
13 of 13 declarations
About 同和药业
Tonghua Dongbao Pharmaceutical Co., Ltd. is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medicines.